Find out more about our Academic Medical Centre and efforts in Academic Medicine
Academic Medicine Executive Committee (AM EXCO)
Find out more about what JOAM do to support AM initiatives
Find out more about the Office of Duke-NUS Affairs and Study Trip to Duke Durham
Guidelines, forms, and templates for Academic Medicine.
Gefitinib is a targeted medicine used to treat non-small cell lung cancer. It can be used as a single agent or in combination with other cytotoxic medicines.
Inform your doctor if any of the following occurs:
Avoid taking:
It is a tablet, to be taken by mouth. It is taken once daily and can be taken with or without food.
If you miss a dose of Gefitinib, take it as soon as you can if it is within 12 hours of the missed dose. If it is over 12 hours since you missed dose, skip the missed dose and go back to your usual dosing. Do not double the dose.
If you overdose on this medicine, inform your doctor immediately.
Do not break or crush the tablet.
Updated on Friday, February 22, 2019
This article is contributed by Department of Pharmacy National Cancer Centre Singapore